For Patients
Book a genomic appointment and track its progress, view test results, and reach our team — all in one place.
Precision oncology for the Philippines
Advancing Precision Cancer Care in the Philippines
Through advanced genomic testing, clinical expertise and global collaborations, LINCS helps bring personalised cancer care closer to Filipino patients.
About Us
Empowering Genomics, Enriching Lives
At Linking Network for Cancer Services Inc. (L!NCS), we believe that precision genomics should be accessible to every Filipino patient, healthcare professional, researcher, and healthcare institution.
Founded with a mission to transform healthcare and research through next-generation sequencing (NGS), our lab is equipped with the latest technology, guided by experts in molecular biology, bioinformatics, and clinical diagnostics.
Our Leadership
The Experts Steering Our NGS Vision
A dynamic team of reputable key opinion leaders known in cancer care, driving precision oncology across the Philippines.
Catherine SC Teh, M.D.
Chair of the Board
Necy S. Juat, M.D.
President & CEO
Jhade Lotus P. Peneyra
Finance & Gen. Support Director
Annielyn Ong-Cornel, M.D.
Sales & Marketing Director
Christina G. Galvez, M.D.
Laboratory & Research Director
Our Network & Labs
Delivering innovation and impact through our global presence and advanced genomics labs.
Manila, Philippines
Hub · SE Asia Genomics Lab
Our Southeast Asia Genomics Lab in Manila drives cutting-edge research and innovation in genomics, bioinformatics, and precision medicine to improve lives across the region.
View on mapOur lab
State-of-the-art facilities enabling world-class genomics research.
Our Test Panels
Genomic Testing Solutions
From focused panels to whole-exome profiling, TARGT delivers actionable genomic insights for solid tumors, hereditary cancers, and complex cases.
TARGT First
Your First Step in Precision Oncology
TARGT First is one of the most focused and affordable pan-solid Cancer Gene panels available, featuring 92 of the most commonly mutated cancer-associated genes with a high level of evidence for both targeted therapy and prognostication.
"Your First Step in Precision Oncology."
92
Actionable Cancer Genes
15 working days
TAT
Why it works
Cost-effective, focused panel covering the most frequently mutated genes in solid tumors.
TARGT Indiegene
Genomics Grounded in Your Community
TARGT Indiegene is a cancer gene panel developed by comprehensively profiling the whole-exome and transcriptome of 3,000+ tumor samples from cancer patients, covering 28 cancer types.
"Genomics Grounded in Your Community."
1,212
Unique Genes
15 working days
TAT
Why it works
Developed on data from 1,500+ Asian patients across 28 cancer types to boost effectiveness in Asia-Pacific populations.
TARGT Absolute
Beyond the Standard Cancer CGP Panel
TARGT Absolute provides a comprehensive report based on whole-exome profiling to match targeted therapy with biomarkers. It uses Cellworks' advanced AI-based Biosimulation Platform.
"From Tissue and Blood, Into Action."
20,000+
Genes Profiled
21 working days
TAT
Why it works
Absolute SoLiQ analyzes ~20,000 genes using dual solid/liquid biopsies - ideal for challenging or rare cases.
Hereditary Cancer Panels
Know Their Genes, Shape Their Futures
From Risk to Response. Guided by Genes. Detects inherited mutations from both parents for all cancer types to enable early prevention and personalized care planning.
"Know Their Genes, Shape Their Futures."
15
to 163 Genes
15 working days
TAT
Why it works
This panel detects inherited mutations to enable early prevention and personalized care planning.
Not sure which panel is right for you?
Talk to our care team → Latest news
All news →News, awards, and milestones
Built for everyone in the network
One platform. Four audiences.
Whether you are a patient, a clinician, a researcher, or a sponsor — there is a path into precision oncology through LINCS.
For Hospitals & Clinics
Onboard your site to our partner network, integrate lab workflows, and bring advanced genomic testing to your patients.
For Researchers
Collaborate on clinicogenomic datasets representing the genomic diversity of the Philippines and Southeast Asia.
For Industry
Accelerate clinical trial recruitment and biomarker discovery with real-world, multi-modal genomic evidence.
Get Involved
Ready to Join the Fight?
Whether you are a patient, provider, or organization, there is a place for you in the LINCS network. Together, we improve quality of care and patient safety.
200+
Partners
10k+
Patients
50+
Programs
FAQ
Frequently Asked Questions
Everything you need to know about booking, testing, and partnering with LINCS.
Still have questions? Reach out to our team — we typically respond within one business day.